Rina Shah

Title: Rina Shah: Innovator in Pharmaceutical Formulations

Introduction

Rina Shah is a prominent inventor based in Gujarat, India. She has made significant contributions to the field of pharmaceutical formulations, particularly in the development of innovative drug delivery systems. Her work focuses on improving the pharmacokinetic profiles of medications, which can lead to enhanced therapeutic outcomes.

Latest Patents

Rina Shah holds 1 patent for her invention related to pharmaceutical formulations. Her patent addresses the pharmacokinetic profile of the SGLT2 inhibitor bexagliflozin. By formulating it as an extended-release tablet, she has demonstrated that it can improve the drug's effectiveness. Compared to standard immediate-release dosage forms, these tablets allow for a lower peak plasma concentration while maintaining therapeutic levels for a desired period. This innovation enables the administration of lower doses while still achieving the same pharmacological effect.

Career Highlights

Rina Shah is currently associated with Theracosbio, LLC, where she continues to advance her research in pharmaceutical sciences. Her work is pivotal in developing formulations that can enhance patient compliance and treatment efficacy.

Collaborations

Rina collaborates with notable professionals in her field, including Feng Wang and Ankit Shrivastava. Their combined expertise contributes to the innovative projects at Theracosbio, LLC.

Conclusion

Rina Shah's contributions to pharmaceutical formulations exemplify the impact of innovation in healthcare. Her work not only advances scientific knowledge but also has the potential to improve patient outcomes significantly.